{"id":46455,"date":"2022-07-21T21:01:51","date_gmt":"2022-07-21T19:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/"},"modified":"2022-07-21T21:01:51","modified_gmt":"2022-07-21T19:01:51","slug":"praesidium-a-utah-startup-closes-first-massive-commercial-deal","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/","title":{"rendered":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal"},"content":{"rendered":"
\n

SAINT GEORGE, Utah–(BUSINESS WIRE)–Praesidium, Inc, a Saint George, Utah-based technology company that specializes in non-contact vital sign detection, announced today that they have finalized a commercial agreement with two other business partners to launch an innovative, next generation \u201cintelligent sleep\u201d mattress early next year. This announcement represents the culmination of nearly a year of research and development collaboration with a leading domestic foam mattress manufacturer and Prius Healthcare, a leading Oldsmar, Florida-based therapeutic support surface innovator in the healthcare industry.\n<\/p>\n

<\/a><\/p>\n

\nPraesidium\u2019s patented BioFi technology will revolutionize the rapidly growing space of Smart Sleep. Consumers will have the ability to adjust the pressure in their mattress in all the traditional ways and track their critically important quantitative vital statistics like Heart Rate, Heart Rate Variability, Respiration, Presence, Bed Exits, Duration in and out of Bed and their qualitative measures around sleep stages, vital sign history, goals, scores, etc. Further, the BioFi technology will use Machine Learning to adjust the pressure of the mattress while constantly assessing how the consumer reacts by interpreting their vital sign data in real time, without any conscious human intervention or prompts. \u201cOver the last several years, consumer awareness and interest in smart sleep technology has gained tremendous traction, however innovation and advancement over that time has been rather lackluster \u2013 a few advancements here and some new features to an App there. We realized that our BioFi technology could truly shift the paradigm in this space and take smart sleep and transform it into intelligent sleep. We knew we needed other leading partners in the sleep space to make this happen, and that\u2019s exactly what we\u2019ve done with this collaborative partnership of innovative industry leaders,\u201d Seth Campbell, Praesidium\u2019s Founder and CEO said.\n<\/p>\n

\n\u201cWe are very pleased to partner with a consumer mattress titan and a paradigm shifting technology company like Praesidium to disrupt the consumer sleep industry. Coupling Praesidium\u2019s BioFi technology with our healthcare-based air mattress components into a leading-edge mattress will provide the consumer with the ultimate restful night\u2019s sleep,\u201d remarked Kevin Farrell, Prius Healthcare\u2019s CEO.\n<\/p>\n

\nThe commercial agreement includes significant volume guarantees for Praesidium\u2019s BioFi sensors and technology over the next several years with initial geographic sales reach concentrated in North America, but quickly scaling throughout Europe and certain Asian markets. Minimum revenue estimates from this commercial agreement approach $70M for Praesidium\u2019s BioFi technology and sensors. More definitive launch plans and additional press releases will be forthcoming from the collaborators as the 2023 launch approaches.\n<\/p>\n

\nAbout Praesidium:<\/b>\n<\/p>\n

\nPraesidium was founded in 2016 to create life detection technologies that could prevent unnecessary tragedy such as children left in hot vehicles. Partnering with scientists from NASA and MIT over the last 5 years, Praesidium has developed BioFi, a patented and proprietary technology that can detect human presence and human vital signs without any contact and even through hard surfaces with extremely high accuracy and precision. For more information see www.BioFi.com<\/a>.\n<\/p>\n

\nAbout Prius Healthcare<\/b>\n<\/p>\n

\nPrius Healthcare USA is an FDA registered organization providing therapeutic support surfaces across the healthcare facility and home health spectrum. The surfaces both treat and prevent pressure ulcers (aka \u201cbedsores\u201d) with various levels of clinical therapy. Founded in 2010, Prius is based in Oldsmar, FL and distributes to all 50 U.S. states and Canada. For more information see www.priushc.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSeth Campbell
\n
Seth.Campbell@biofi.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAINT GEORGE, Utah–(BUSINESS WIRE)–Praesidium, Inc, a Saint George, Utah-based technology company that specializes in non-contact vital sign detection, announced today that they have finalized a commercial agreement with two other business partners to launch an innovative, next generation \u201cintelligent sleep\u201d mattress early next year. This announcement represents the culmination of nearly a year of research … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46455","6":"format-standard","7":"category-industry"},"yoast_head":"\nPraesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Praesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAINT GEORGE, Utah–(BUSINESS WIRE)–Praesidium, Inc, a Saint George, Utah-based technology company that specializes in non-contact vital sign detection, announced today that they have finalized a commercial agreement with two other business partners to launch an innovative, next generation \u201cintelligent sleep\u201d mattress early next year. This announcement represents the culmination of nearly a year of research ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T19:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Praesidium, a Utah Startup, Closes First Massive Commercial Deal\",\"datePublished\":\"2022-07-21T19:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/\"},\"wordCount\":572,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005929\\\/en\\\/1520940\\\/21\\\/Heart_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/\",\"name\":\"Praesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005929\\\/en\\\/1520940\\\/21\\\/Heart_Logo.jpg\",\"datePublished\":\"2022-07-21T19:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005929\\\/en\\\/1520940\\\/21\\\/Heart_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005929\\\/en\\\/1520940\\\/21\\\/Heart_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Praesidium, a Utah Startup, Closes First Massive Commercial Deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/","og_locale":"en_US","og_type":"article","og_title":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend","og_description":"SAINT GEORGE, Utah–(BUSINESS WIRE)–Praesidium, Inc, a Saint George, Utah-based technology company that specializes in non-contact vital sign detection, announced today that they have finalized a commercial agreement with two other business partners to launch an innovative, next generation \u201cintelligent sleep\u201d mattress early next year. This announcement represents the culmination of nearly a year of research ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-21T19:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal","datePublished":"2022-07-21T19:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/"},"wordCount":572,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/","url":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/","name":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg","datePublished":"2022-07-21T19:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220721005929\/en\/1520940\/21\/Heart_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/praesidium-a-utah-startup-closes-first-massive-commercial-deal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Praesidium, a Utah Startup, Closes First Massive Commercial Deal"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46455"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46455\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}